Matt Griffor
Pfizer (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, DNA Repair Mechanisms, Cancer therapeutics and mechanisms, Protease and Inhibitor Mechanisms, Cell Adhesion Molecules Research
Most-Cited Works
- → SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1(2010)890 cited
- → Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271(2008)380 cited
- → Selective Inhibition of Casein Kinase 1ϵ Minimally Alters Circadian Clock Period(2009)179 cited
- → Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design(2009)107 cited
- → Design and Synthesis of Truncated EGF-A Peptides that Restore LDL-R Recycling in the Presence of PCSK9 In Vitro(2014)72 cited
- → The catalytic mechanism of cyclic GMP‐AMP synthase (cGAS) and implications for innate immunity and inhibition(2017)67 cited
- → Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide(2016)55 cited
- → Cloning and Functional Characterization of an NAD + -Dependent DNA Ligase from Staphylococcus aureus(2001)51 cited
- → Crystal structure of activin receptor type IIB kinase domain from human at 2.0 Å resolution(2007)32 cited
- → Structure of the adenylation domain of NAD+-dependent DNA ligase fromStaphylococcus aureus(2009)13 cited